Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial
Authors:
Open Access
- 11 July 2022
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 253, 59-66
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Serum potassium levels and the risk of atrial fibrillationInternational Journal of Cardiology, 2013
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsNew England Journal of Medicine, 2011
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- What is the optimal serum potassium level in cardiovascular patients?JACC, 2004
- Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Diuretic Therapy for Hypertension and the Risk of Primary Cardiac ArrestNew England Journal of Medicine, 1994
- The effect of potassium and potassium plus magnesium supplementation on ventricular extrasystoles in mild hypertensives treated with hydrochlorothiazideInternational Journal of Cardiology, 1989
- Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction.Circulation, 1985
- Potassium levels in serum and plasmaClinica Chimica Acta, 1970